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Abstract 
Background: The aim of this project was to collate and contrast patient concerns from a 
range of different head and neck cancer follow-up clinics around the world. Also, we sought 
to explore the relationship, if any, between responses to the Patient Concerns Inventory (PCI) 
and overall quality of life (QOL). 
Methods: Nineteen units participated with intention of including 100 patients per site as 
close to a consecutive series as possible in order to minimise selection bias. 
Results: There were 2136 patients with a median (IQR) total number of PCI items selected of 
5 (2-10). ‘Fear of the cancer returning’ (39%) and ‘dry mouth’ (37%) were most common.  
Twenty-five percent (524) reported less than good QOL. 
Conclusion: There was considerable variation between units in the number of items selected 
and in overall QOL, even after allowing for case-mix variables. There was a strong 
progressive association between the number of PCI items and QOL.
KEYWORDS
Head and Neck Cancer; Quality of life; Patient Concerns Inventory; Patient Prompt list
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1.INTRODUCTION
The number of cancer cases across the world increased by one third between 2005 and 2015. 
The main influences were population growth and increasing age.1 In 2018, there will be over 
18 million new cancer cases and nearly 10 million cancer deaths.2 Head and neck cancer 
(HNC) is a global problem and rates continue to climb with the increase in number of 
oropharyngeal cancers (OPC) ascribed to human papillomavirus (HPV).3
Patient reported outcome measures (PROM) are an established component of cancer 
outcomes reporting.4 Publications related to PROM reflect international interest with papers 
from Africa, Asia, Australia/Oceania, Europe, North America, and South America. Health 
related quality of life (HRQOL) assessment is embedded in many clinical trials. 5 Over 6000 
cancer patients pooled from randomized controlled trials and using the European 
Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 showed differences 
between cancer types and the effects of age on HRQOL.6 In a critical review, Aggarwal and 
co-workers summarised global radiation therapy research between 2001-2015 and reported 
increasing numbers of HRQOL papers from a range of different countries.7
HRQOL evaluation makes a positive difference in clinical practice 8 and research around the 
expression of concerns during follow-up consultations is ongoing. 9 This approach supports 
patient-centred interventions. 10 Following HNC treatment there is a large array of potential 
issues patients wish to discuss. This led to the development of the Patient Concerns Inventory 
(PCI) as an item prompt list to aid clinical consultations and promote multi-professional 
involvement for patients .11 There are subtle differences in items and their frequency reported 
by HNC patients by site (oral, oropharyngeal, laryngeal and other) and stage (early, late).12
Most publications relating to the PCI have been UK based and thus far there is a lack of 
evaluation across a wide variety of healthcare settings. There are likely to be clinical, social, 
cultural, spiritual and health economic variances. Recognising concerns common across 
centres and reflecting on differences should aid clinicians and their colleagues from multi-
professional backgrounds to consider ways to improve the post-treatment support for 
patients.
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The aim of this project was to collate and contrast PCI responses from a range of different 
head and neck cancer follow-up clinics around the world. Also, we sought to explore the 
relationship, if any, between responses to the PCI and overall QOL. 
2.MATERIALS AND METHODS
Nineteen units from around the globe participated (Table 1) and Aintree University Hospital 
in Liverpool was the lead co-ordinating site . The intention was to acquire at least 100 
patients per site and as close to a consecutive series as possible to minimise selection bias. 
The sample size was a pragmatic decision based on the likely number of patient responses 
achievable within a reasonable timeframe.  Eligible patients were those following head and 
neck cancer treatment, aged 18-89 years, and attending routine clinic consultations. Patients 
were free from active cancer (no time limit) and their treatment was with curative intent. 
Those successfully treated for recurrence and late effects such as osteoradionecrosis (ORN) 
were also eligible. Patients were ineligible if they had cognitive impairment, significant 
psychiatric illness or with thyroid or skull base cancer. Eligible patients attending several 
clinics were only included once.  Units were aware of patient identity but their submitted data 
was anonymous. Collaborators approached local medical health boards or University 
Institutes regarding local ethical approval and sponsorship and receipt of such approval was 
required centrally. The data collection period was in large part during 2018, when the data 
was submitted to Aintree. The exception was Aintree itself with consecutive cases from 
November 2011 to January 2013; this was because Aintree is currently involved in a 
randomised trial of the PCI.
The PCI as developed at Aintree University Hospital in collaboration with Edge Hll 
University and consists of 56 specific clinical items (see Figure 5 to see a list of items) and 
one free-text ‘others’ box, and is an item prompt list which patients select from before their 
appointment. These items can be grouped within domains 13 of physical and functional well-
being (29 items), treatment related (4 items), social care and social well-being (9 items) and 
psychological, emotional and spiritual well-being (14 items). The PCI also contains a list of 
18 professionals who patients might want to talk with.  For this international study this list 
was excluded because it is specific to the UK and job roles and titles do vary between 
countries. Thus, only a single sheet paper version of the PCI symptom and problem prompt 
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list was created. Also, a single question about QOL was included for analysis in relation to 
the PCI. The overall QOL question from the University of Washington QOL questionnaire 
(UW-QOLv4) was chosen and this asks patients to rate their overall QOL during the past 7 
days.14 Patients are asked to consider not only physical and mental health, but also other 
factors, such as family, friends, spirituality or personal leisure activities important to their 
enjoyment of life. The response options for the overall QOL question are ‘outstanding’, ‘very 
good’,’ good’, ‘fair’, ‘poor’ and ‘very poor’. The main reason for including this single 
question about QOL was that the primary outcome measure in an ongoing multi-centre 
randomised trial9 is the percentage of patients reporting less than good overall QOL.  The 
response options for the overall QOL question are ‘outstanding’, ‘very good’,’ good’, ‘fair’, 
‘poor’ and ‘very poor’. The analyses we present  use this dichotomy, i.e. where the responses 
of ‘fair’, ‘poor’ and ‘very p or’ are taken as being ‘less than good’. The PCI and UW-QOLv4 
have already been translated into various languages and these were used to create the single 
page form used in this study. Where there was no translated versions a standard forward and 
backward translation process was followed with consensus for any discrepancies. 
Units collected categorical clinical and demographic details on each patient for Age (<55, 55-
64, 65-74, ≥75), Gender (Male, Female), Clinical stage (Early stage 1-2 or Late stage 3-4), 
Site (Oral, Oropharynx, Larynx, Other), Surgery (Yes, No) Radiotherapy (Yes, No), 
Chemotherapy (Yes, No), and Months from Primary diagnosis (<12, 12-23, 24-59, ≥60). 
Each unit entered data into a pre-prepared excel worksheet which was submitted centrally via 
secure email for collation into a single SPSS (Version 25) dataset. 
Statistical method: 
Given the skewed nature of the number of PCI items selected, both in total and particularly in 
the domains, we created binary PCI variables with the cut-off determined by the median 
number of items selected. This approach avoided any subjective selection of cut-off values 
and allowed for consistency of approach across domains in analysis and presentation. Funnel 
plots presenting the percentage of patients selecting more than the median value for the study 
sample as a whole are shown for each unit against their number of cases. A red reference line 
represents the overall percentage of patients who reported more than the median number of 
PCI items.  Control limits are often shaped like a ‘funnel’ and serve as boundaries15 that 
represent the bounds of statistical confidence around the average value. Unit results outside 
these boundaries can be considered outliers in that the chance of results being there due to 
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chance alone is very small (0.2%) for the outer limits, slightly higher (5%) for the inner 
limits. When unit results do fall outside, these are inconsistent with the overall sample result 
in relation to their sample size, implying that something else (non-random) is happening, for 
example systematic organisational, quality of care or cultural differences. Some funnel plots 
present unit variation per se and others after case-mix adjustment. This adjustment was 
achieved using logistic regression modelling with each binary PCI variable in turn as the 
dependent variable and the case-mix variables as independent predictors. The case-mix 
variables for this and other adjustment analyses in this paper were  Age (<55, 55-64, 65-74, 
≥75), Gender (Male, Female), Clinical stage (Early stage 1-2 or Late stage 3-4), Site (Oral, 
Oropharynx, Larynx, Other), Treatment (Surgery only, Radiotherapy and/or chemotherapy 
without surgery, Surgery with radiotherapy and/or chemotherapy) and Months from Primary 
diagnosis (<12, 12-23, 24-59, ≥60). Expected patient probabilities were derived from each 
regression, and were summed over the set of patients for each unit to give expected patient 
numbers. The observed to expected ratio (O/E) of numbers for each unit multiplied by the 
overall sample rate gave the adjusted rate for each unit. Funnel plots were similarly 
constructed showing the percentage of patients reporting less than good overall QOL.
Binary regression (STATA binreg procedure, rr link option) was used to assess the 
association of case-mix to PCI (total items selected and by domain) and to overall QOL being 
less than good. Risk ratios were estimated as were 95% confidence intervals, with 
adjustments made for other case-mix variables as independent predictors and for unit 
clustering effects (by using the option 'cluster'). Binary regression with adjustment for unit 
clustering was also performed for each of the PCI items in turn as a predictor of overall QOL 
being less than good. 
The study co-ordinator received ethical approval documents from each individual unit. Over-
arching ethical approval was gained from West of Scotland Research Ethics Service; IRAS 
project ID: 234413, REC reference: 18/WS/0152. The study was unfunded.
3.RESULTS
Nineteen units participated with a median (IQR) of 100 (89-140) cases submitted, range 50-
204, In total,  data were submitted on 2136 patients, and 70% (1488/2135) were males.  
Twenty-four percent (505/2132) were aged under 55 years, with 32% (686) 55-64 years, 32% 
(672) 65-74 years and 13% (269) 75 years or older. Just over half (55%, 1157/2115) had 
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‘late’ stage 3-4 tumours, and tumour location for 48% (1025/2129) was oral, 20% (424) 
oropharynx, 20% (419) larynx and 12% (261) ‘other’. About one-third (36%, 763/2122) were 
treated by surgery alone, 23% (482) by radiotherapy and/or chemotherapy without surgery, 
while 41% (877) had surgery combined with radiotherapy and/or chemotherapy. Specifically, 
77% (1642/2131) received surgery, 62% (1326/2130) radiotherapy and 32% (689/2128) 
chemotherapy.  One quarter (27%, 560/2073) were within 12 months of diagnosis, 20% (416) 
within 12-23 months, 30% (620) within 24-59 months and 23% (477) at 60 months or later. 
The median (IQR) total number of PCI items selected was 5 (2-10), range 0-48 items, mean 
6.95 and 48% (1026/2136) with 6 or more PCI items overall . Corresponding results for each 
PCI domain were: Physical and functional well-being 3 (1-6), 0-28, 4.31 and 47% 
(1013/2136) with 4 or more items; Treatment related 0 (0-1), 0-4, 0.38 and 31% (665/2136) 
with 1 or more items; Social care and social well-being 0 (0-1), 0-9, 0.75 and 41% 
(869/2136) with 1 or more items; sychological, emotional and spiritual well-being 1 (0-2), 
0-13, 1.50 and 36% (773/2136) with 2 or more items. There was considerable variation 
between units in the number of items their patients selected (Figure 1), and a four-fold 
difference in the mean total number selected (Figure 2). However, there was considerable 
variation in unit case-mix (Table 2). Figure 3 presents funnel plots showing unit variation 
both before and after case-mix adjustment in the number of patients selecting 6 or more PCI 
items overall.  Case-mix adjustment had minimal impact on unit variation implying there 
remain stronger systematic unit differences.  Figure 4 shows case-mix adjusted funnel plots 
for PCI domains and though most units follow the pattern delineated by the funnel some units 
had a tendency for their patients to select more items across all domains, and others to select 
fewer. One unit was excluded from all adjusted analyses because no data was submitted for 
one of the case-mix variables (Table 2). 
Binary regression assessed the association of each case-mix variable with the likelihood of 
endorsing more than the median number of PCI items, after adjustment for other case-mix 
variables as independent predictors and adjustment for unit clustering.  Separate models 
evaluated each PCI score [i.e. total score, physical function, treatment-related issues, social 
care/social well-being, and psychological/emotional/spiritual well-being]. (Table 3). The first 
column of results shows univariate case-mix variable variation in the percentage of patients 
selecting ≥6 PCI items overall and greater percentages were observed  for females, patients 
with later stage tumours, patients having radiotherapy and/or chemotherapy and patients 
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within 12 months of diagnosis. Overall and across domains the adjusted risk ratios suggest a 
consistency for females to be more likely to select more items, particularly psychological 
emotional and spiritual items, though some of the confidence intervals about these risk ratios 
did include the possibility of no added risk (i.e. a risk ratio of 1.00) . Similarly there was also 
consistency observed in risk ratios greater than 1.00 for patients treated with radiotherapy 
and/or chemotherapy, and patients within the first 12 months since diagnosis, though again 
many of the confidence intervals included the possibility of no added risk.. There generally 
seemed little association with tumour site whilst tumour stage seemed more specifically 
relevant to physical functioning. 
Figure 5 shows the PCI items selected by patients over the whole sample, the most common 
of which were ‘fear of the cancer returning’ (39%) and ‘dry mouth’ (37%). Other items 
selected by 20-29% of patients were ‘chewing/eating’, ‘swallowing’, ‘speech/voice/being 
understood’, ‘dental health/teeth’, ‘fatigue/tiredness’, ‘salivation’, ‘pain in the head and 
neck’, ‘cancer treatment’ and ‘mouth opening’. ‘Dry mouth’ was in the top five items 
selected for 17 of the 19 units and in the top ten items selected for 18 units (Table 4) and 
‘fear of the cancer returning’ was in the top ten selected items for all 19 units.  In all, across 
19 units there were 20 different PCI items that made their way into the top five items selected 
and 35 items into the top ten selected. Other free-text items were few in number (2%, 
51/2136); 3 were related to work, 3 to itchy skin and 3 to bad breath, whereas the remainder 
were a disparate collection of non-specific issues, such as lip ulcer, tremor, post-operative 
hair growth in mouth, dimension of tracheostomy stoma, loneliness, facial numbness, 
cramps, aching joints, CT findings, blocked tear duct. 
Overall QOL was known for 2099 patients and was reported by 4% (94) of patients as 
‘outstanding’, 30% (625) as ‘very good’, 41% (856) as ‘good’, 17% (362) as ‘fair’, 6% (123) 
as ‘poor’ and 2% (39) as ‘very poor’. Thus overall QOL was less than good for 25% 
(524/2099) and Figure 6 presents funnel plots showing unit variation both before and after 
case-mix adjustment. Case-mix adjustment made little difference implying stronger 
systematic unit differences exist, though these differences were smaller than seen for 
numbers of PCI items selected.   Binary regression assessed the association of each case-mix 
variable with the percentage of patients reporting less than good QOL after adjustment for 
other case-mix variables as independent predictors and for unit clustering (Table 5). The 
adjusted risk ratios suggest females were more likely to report less than good QOL, risk ratio 
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1.27, 95%CI: 1.05-1.53.  There were also higher risk ratios  observed for late tumour stage 
and use of radiotherapy/chemotherapy though confidence intervals about these risk ratios do 
include the possibility of no increased  risk. Overall, these  case-mix variables were less 
compelling as predictors of QOL than PCI predictors of QOL, as seen in the results from 
separate analyses using PCI scores as predictors  in which a greater number of PCI items 
endorsed was associated with poorer QOL (Figure 7). Similar (though less striking)  
progressive associations were seen within each PCI domain (Figure 8).
Binary regression also assessed the association of each PCI item with less than good QOL, 
adjusting for unit clustering, and 38 of the 56 were significant at the p<0.001 level and all but 
three (appetite, hearing and carer) were significant at p<0.05. All 56 had risk ratios over 1.00, 
with 55 over 1.30, median (IQR) risk ratios 1.75 (1.57-1.92) range 1.05-2.34. This again 
supports the number of items selected either overall or by domain being progressive 
indicators.   
4.DISCUSSION
This is the first time that an item prompt list such as the PCI has been used across such a 
diverse number of units in different healthcare settings. In routine clinical practice it is 
feasible to use both the UW-QOLv4 and PCI in digital format with algorithms to identify 
immediately those patients doing badly and what issues they wish to talk about.11 However, 
in situations where digital systems for collecting patient reported outcomes are not used, a 
single sheet paper PCI is a way of alerting clinical teams as to which patients need additional 
support. A PCI approach in routine follow-up clinics could possibly result in a clinically 
meaningful and significant difference in quality of life (QOL), emotional dysfunction, and 
distress at one year and is the subject of ongoing research. 9 The primary outcome measure 
for this ongoing randomised trial is the percentage of patients reporting less than good overall 
QOL, hence the inclusion of  the one item UW-QOLv4 question in our study. The PCI is a 
condition specific prompt list and is different to other tools such as the Cancer Survivors' 
Survey of Needs (CSSN), and Cancer Survivors' Unmet Needs measure (CaSUN).16,17 
There are several limitations to this study. It  was non-funded with self-selecting units and 
with no attempt to obtain representation from every continent, nor within each country. The 
intention was for consecutive patients to be approached to reduce selection bias and although 
reports from collaborators suggest that relatively few patients declined it is a limitation of the 
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study that no log was made of such patients and consequently the accrual rate for the study is 
unknown. Missing data in selected patients was minimal. Contributing units reported little 
difficulty in translating the PCI. Some words caused confusion such as ‘activity’ and 
‘regurgitation’ and some items may not always have seemed applicable to some healthcare 
settings, such as having access to financial benefit support, nursing care at home and 
gastrostomy feeding tubes. Regarding the question of quality of life, the term ‘outstanding’ is 
extreme for some cultures, where ‘very good’ is the best to be expected. In some cultures, it 
might be considered unacceptable to ask about certain topics such as intimacy and sex; 
however in using the PCI patients can choose not to identify certain issues and focus on other 
aspects. If the PCI is to be used more widely it would be appropriate to undertake further 
cross-cultural translation studies to help frame each item within the context of the individual 
healthcare setting, which w uld help determine the utility of using the item prompt list. The 
cohort were all first-time users of the PCI though in future a longitudinal study of PCI 
responses would help reveal any temporal differences in items within clinical settings. In 
terms of data analysis, we looked at variation between units by the case-mix factors used and 
future studies could include other aspects such as comorbidity, educational level, occupation 
and carer support.
Patient Concerns Inventory
There are clear systematic differences between units in the number and type of items selected 
after case-mix adjustment. Some units chose more items across all domains. This is most 
likely to reflect cultural differences but possibly more pertinent are the expectations of  
patients as to what they want to talk about in their consultations and their expectations based 
on previous use of their local health care systems.  It may reflect the way the PCI is framed in 
the clinical setting and also linguistic issues. Lack of access to information about cancer 
treatment, superstitious beliefs and illiteracy may also be contributory factors. There are 
likely to be differences between countries with developing healthcare systems and those with 
more resources to help rehabilitation and adaptation.  Potentially, there are also differences in 
disclosure between countries in respect of doctor and patient communication, e.g. a greater 
cultural willingness in general  to disclose rather than to conceal problems and a  higher 
generalized tendency to report symptoms. Inevitably there will be cross-cultural differences 
in respect of family and care support and spiritual/existential aspects of having cancer. All 
these areas need further research involving qualitative methodology. 
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There were similarities to earlier smaller single unit reports regarding the most common 
items selected.12 Certain items were very common and impact across all patients in respect to 
their cancer treatment.  ‘Dry mouth’ was in the top five items selected for 17 of the 19 units 
and in the top ten items selected for 18 units (Table 4) and ‘fear of the cancer returning’ was 
in the top ten selected items for all 19 units. It is appropriate to advocate treatments that 
minimise xerostomia as a side effect, such as the use of IMRT. Also, when balancing risks 
versus benefits consider withholding radiotherapy following surgery and saving that option 
for salvage. 18 It is important to encourage patients to talk about these items as there are 
interventions available. Some are informal in the clinical consultation through recognition 
and empathy, others involve formal counselling strategies such as the AFTER intervention 
for fear of recurrence.19
  
This is most likely to reflect cultural differences but possibly more pertinent are the 
expectations of  patients as to what they want to talk about in their consultations and their 
expectations based on previous use of their local health care systems.  It may reflect the way 
the PCI is framed in the clinical setting and also linguistic issues. Lack of access to 
information about cancer treatment, superstitious beliefs and illiteracy may also be 
contributory factors. There are likely to be differences between countries with developing 
healthcare systems and those with more resources to help rehabilitation and adaptation.  
Potentially, there are also differences in disclosure between countries in respect of doctor and 
patient communication, e.g. a greater cultural willingness in general  to disclose rather than to 
conceal problems and a  higher generalized tendency to report symptoms. Inevitably there 
will be cross-cultural differences in respect of family and care support and 
spiritual/existential aspects of having cancer. All these areas need further research involving 
qualitative methodology. 
Quality of life
Previous research found a relationship between number of symptoms, functional and physical 
status and overall QOL.20  In our study, the adjustment for patient characteristics  made little 
difference to unit variations in overall QOL. The number of PCI items appeared more 
strongly associated with overall  QOL than the case-mix variables. Almost all of the PCI 
items were significantly predictive at the p<0.05 level and all 56 had risk ratios over 1.00. 
This would imply that the count of just about any subset of PCI items selected will be 
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progressively predictive of  overall QOL; this is reflected in Figures 7 and 8 with increasing 
PCI domain item totals and with the total number of items being the most predictive.   
The PCI approach facilitates tailored multidisciplinary team support within an holistic and 
individualized framework. Further research is required to assess how the PCI approach alters 
the consultation dynamic across different cultural and health care settings. There is a lack of 
PCI data from some countries (e.g. USA and Mainland China) and so the next step is to 
construct representative patient profiles for each continent and to include additional case-mix 
factors.  Also, there needs to be evidence on how the use of the PCI might lead to better QOL 
outcomes. 9 Recognising and sharing differences in patient experiences across health systems 
provides an opportunity to reflect on what we can learn from others and how we might best 
focus on areas for improvement.  
CONCLUSION
Although there are similarities in the PCI between the 19 units, differences do exist and are 
larger than what would be expected by case-mix factors alone. It is likely that the PCI reflects 
subtle differences in priorities across cultures that need to be addressed in order to improve 
QOL outcomes.  
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1
Table 1. Units participating in study  
Abbreviated 
description Description Cases
Australia Royal Brisbane Hospital 100
Belgium Unit Liège, 203
Brazil Unit, Rio de Janeiro, 77
Chile Instituto Nacional del Cancer, Santiago, 100
France Gettec French Group 204
Germany Unit, Göttingen 140
India-A Amrita Institute, Kochi, Kerala, 100
India-T Tata Memorial Hospital 100
Italy University Hospital of Modena 117
Malaysia University of Malaya 58
Poland Wrocław Medical University 79
Romania Emergency County Hospital, Cluj-Napoca 103
Serbia City of Nis 100
Sweden-S Sahlgrenska University Hospital Gothenburg 108
Sweden-U Umeå University Hospital and Uppsala University Hospital 89
Taiwan Kaohsiung Chang Gung Memorial Hospital 157
Turkey University of Istanbul 103
UK-L Aintree Hospital Liverpool 148
UK-S Morriston Hospital Swansea 50
Total 2136
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2
Table 2.  Case-mix variation between units
No.: Number of patients
Sex Age Stage Tumour site Treatment Time from diagnosis
Mean # 
PCI 
items
Cases No. (%) female
No. (%) 
≥65 years
No. (%) 
Late 
No. (%) 
oral
No. (%) 
oro-
pharynx
No. (%) 
larynx
No. (%) 
other 
location
No. (%) 
surgery alone
No. (%)  
RT/CT 
without 
surgery
No. (%)  
Surgery & 
RT/CT
No. (%) 
≥24 months
Turkey 16.4 103 40 (39) 20 (19) 71 (69) 90 (87) 3 (3) 6 (6) 4 (4) 32 (31) 5 (5) 66 (64) 64 (62)
Chile 14.5 100 51 (51) 24 (24) 55 (55) 57 (57) 4 (4) 10 (10) 29 (29) 56 (56) 9 (9) 35 (35) 15 (15)
Romania 9.7 103 11 (11) 43 (42) 47 (46) 0 (0) 3 (3) 76 (74) 24 (23) 38 (37) 20 (19) 45 (44) 62 (60)
Serbia 9.5 100 49 (49) 48 (48) 57 (57) 78 (78) 22 (22) 0 (0) 0 (0) 14/99 (14) 16/99 (16) 69/99 (70) 36 (36)
Sweden-S 8.4 108 35 (32) 41 (38) 31 (29) 15 (14) 76 (70) 8 (7) 9 (8) 8 (7) 92 (85) 8 (7) 62 (57)
Brazil 7.8 77 15 (19) 46 (60) 59 (77) 30 (39) 12 (16) 33 (43) 2 (3) 28/76 (37) 20/76 (26) 28/76 (37) 0 (0)
France 6.9 204 62/203 (31) 106/203 (52) 121/197 (61) 50/200 (25) 63/200 (32) 51/200 (26) 36/200 (18) 31/198 (16) 60/198 (30) 107/198 (54) 119/200 (60)
Belgium 6.7 203 54 (27) 112 (55) 122 (60) 39 (19) 81 (40) 69 (34) 14 (7) 53 (26) 70 (34) 80 (39) 107 (53)
Sweden-U 5.7 89 17 (19) 44 (49) 62 (70) 18 (20) 48 (54) 12 (13) 11 (12) 10 (11) 50 (56) 29 (33) 31 (35)
Italy 5.4 117 34 (29) 73 (62) 74 (63) 41 (35) 28 (24) 41 (35) 7 (6) 57 (49) 29 (25) 31 (26) 81 (69)
UK-S 5.2 50 15 (30) 26/48 (54) 30 (60) 43 (86) 4 (8) 0 (0) 3 (6) 22/49 (45) 4/49 (8) 23/49 (47) 16 (32)
India-T 5.2 100 14 (14) 15 (15) 67 (67) 75 (75) 6 (6) 8 (8) 11 (11) 9 (9) 20 (20) 71 (71) 85 (85)
India-A 5.1 100 25 (25) 35 (35) 36 (36) 56 (56) 1 (1) 6 (6) 37 (37) 36/99 (36) 1/99 (1) 62/99 (63) 47 (47)
Poland 5.1 79 21 (27) 49 (62) 66 (84) 5 (6) 4 (5) 55 (70) 15 (19) 43/78 (55) 28/78 (36) 7/78 (9) 40 (51)
Australia 5.0 100 41 (41) 50/99 (51) 49 (49) 91 (91) 6 (6) 0 (0) 3 (3) 57 (57) 3 (3) 40 (40) 47 (47)
Taiwan 4.6 157 12 (8) 43 (27) 88 (56) 99 (63) 28 (18) 9 (6) 21 (13) 63 (40) 29 (18) 65 (41) 118 (75)
Germany 4.6 140 64 (46) 67 (48) 45 (32) 124 (89) 0 (0) 0 (0) 16 (11) 109 (78) 0 (0) 31 (22) 83 (59)
Malaysia 4.4 58 39 (67) 25 (43) 11/44 (25) 53/55 (96) 0/55 (0) 0/55 (0) 2/55 (4) 25/55 (45) 3/55 (5) 27/55 (49) No data 
UK-L 3.7 148 48 (32) 73 (49) 66 (45) 61 (41) 35 (24) 35 (24) 17 (11) 72 (49) 23 (16) 53 (36) 83/147 (56)
Overall 7.0 2136 647/2135 
(30)
940/2132 
(44)
1157/2115 
(55)
1025/2129 
(48)
424/2129 
(20)
419/2129 
(20)
261/2129 
(12)
763/2122 
(36)
482/2122 
(23)
877/2122 
(41)
1096/2073 
(53)
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Table 3. Case-mix and number of patients selecting more than a specified number of PCI items, overall and by PCI domain.  
≥6  PCI items selected overall
≥4 Physical 
function items 
selected
≥1 Treatment 
related issues 
selected
≥1 Social care and 
social well-being 
items selected
≥2 Psychological, 
emotional and 
spiritual well-being 
items selected
Raw data Risk ratio* unadjusted
Risk ratio* after 
adjustment
Risk ratio* after 
adjustment
Risk ratio* after 
adjustment
Risk ratio* after 
adjustment
Risk ratio* after 
adjustment
Gender Male 45% (665/1488) Reference
Female 56% (360/647) 1.25 (1.14-1.36) 1.28 (1.11-1.47) 1.26 (1.13-1.41) 1.06 (0.82-1.37) 1.11 (0.93-1.33) 1.45 (1.24-1.68)
<55 48% (242/505) ReferenceAge at 
diagnosis 55-64 50% (346/686) 1.05 (0.94-1.18) 1.04 (0.90-1.19) 1.04 (0.88-1.24) 0.80 (0.67-0.96) 0.97 (0.84-1.11) 0.94 (0.77-1.15)
65-74 47% (318/672) 0.99 (0.87-1.11) 0.99 (0.83-1.19) 1.01 (0.84-1.22) 0.75 (0.57-0.99) 0.87 (0.70-1.07) 0.77 (0.60-0.99)
≥75 43% (117/269) 0.91 (0.77-1.07) 0.91 (0.70-1.19) 1.06 (0.81-1.39) 0.69 (0.44-1.07) 0.81 (0.64-1.04) 0.72 (0.53-1.00)
Stage Early 41% (395/958) Reference
Late 54% (624/1157) 1.31 (1.19-1.43) 1.13 (0.98-1.30) 1.25 (1.09-1.45) 0.98 (0.79-1.20) 1.00 (0.84-1.20) 1.09 (0.92-1.29)
Site Oral 48% (490/1025) Reference
Oropharynx 52% (219/424) 1.08 (0.97-1.21) 0.93 (0.79-1.10) 1.04 (0.87-1.24) 0.90 (0.64-1.28) 0.72 (0.54-0.96) 0.96 (0.69-1.34)
Larynx 45% (189/419) 0.94 (0.83-1.07) 0.94 (0.71-1.25) 0.96 (0.75-1.22) 0.94 (0.70-1.28) 1.10 (0.79-1.53) 1.10 (0.76-1.60)
Other 48% (124/261) 0.99 (0.86-1.15) 0.91 (0.70-1.17) 0.95 (0.78-1.16) 1.00 (0.70-1.42) 0.89 (0.59-1.34) 1.02 (0.72-1.43)
Treatment Surgery only 37% (286/763) Reference
RT+/-CT only 51% (246/482) 1.36 (1.20-1.55) 1.34 (1.04-1.74) 1.23 (1.00-1.52) 1.19 (0.76-1.86) 1.17 (0.89-1.53) 1.04 (0.77-1.39)
Surgery & RT+/-CT 56% (489/877) 1.49 (1.33-1.66) 1.41 (1.10-1.81) 1.26 (1.04-1.52) 1.31 (0.93-1.86) 1.34 (1.04-1.72) 1.20 (0.90-1.59)
<12 months 56% (315/560) ReferenceTime from 
diagnosis 12-23 months 50% (206/416) 0.88 (0.78-0.99) 0.87 (0.72-1.05) 0.90 (0.76-1.06) 0.84 (0.64-1.11) 0.89 (0.69-1.14) 0.88 (0.66-1.18)
24-59 months 42% (260/620) 0.75 (0.66-0.84) 0.74 (0.59-0.93) 0.80 (0.64-0.99) 0.73 (0.48-1.10) 0.81 (0.64-1.03) 0.77 (0.55-1.06)
≥60 months 47% (225/477) 0.84 (0.74-0.95) 0.85 (0.68-1.06) 0.84 (0.68-1.04) 0.84 (0.55-1.29) 0.83 (0.62-1.12) 0.85 (0.62-1.16)
*risk ratio  (with 95% confidence interval) for unadjusted and then adjusted for other case-mix factors and for within-unit clustering (n=2053 with all case-mix known)
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Table 4.  Which PCI items appeared most often in the top ten selected in the 19 units
1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th
Turkey Chewing/Dry mouth/Speech Swallowing Appearance Anxiety/Mouth O/Salivation Fear Mood
Chile Fear Cancer T Dental Dry mouth Chewing Speech Wound H Pain HN/ Swallowing Salivation
Romania Speech Fear Fatigue Coughing Angry/Dry mouth Breathing Smell Mucus/ Pain HN
Serbia Dependents Fear Support Swallowing Depression Spiritual Regret/Taste Breathing Chewing
Sweden-S Dry mouth Fear Mucus Swallowing Salivation Chewing/Mouth O Dental Cancer T Fatigue
Brazil Fear Dry mouth Swallowing Pain HN Fatigue Taste Mucus Coughing/Shoulder Anxiety/Smell
France Fear Dry mouth Salivation Pain HN Chewing Fatigue Dental Speech Appetite Anxiety/Sleeping
Belgium Fear Dry mouth Fatigue Speech Salivation Chewing Anxiety/Pain HN Appetite Sleeping
Sweden-U Dry mouth Fear/Mucus Salivation Taste Dental health Swallowing Fatigue Chewing Cancer T
Italy Dry mouth Fear/Mucus Swallowing Chewing/Fatigue Salivation Dental Pain HN Speech
UK-S Chewing/Fear Depression/Dry mouth Sore Mouth Anxiety/Salivation Pain Elsewhere/ Mouth O Cancer T/Energy levels/Fatigue
India-T Cancer T Dry mouth Dental Mouth O Chewing Speech/Taste Fear Angry Swallowing
India-A Chewing/Fear/Speech Coughing Mouth O Mucus Dry mouth Pain HN Anxiety Swallowing/Fatigue
Poland Dry mouth Speech Coughing/Mucus/Swallowing Fear Taste Weight Breathing Fear of adverse events/Mood
Australia Fear Chewing Dry Mouth/Speech Dental Fatigue/Mouth O Pain HN Taste Cancer T
Taiwan Dental health Chewing Dry mouth Swallowing Salivation Mouth O Fatigue Appearance Speech Fear
Germany Fear Chewing/Dry mouth Cancer T/Fatigue Dental Swelling Swallowing  Mouth O Appetite/Pain HN
Malaysia Dry mouth Fear Chewing Dental Cancer T/Mouth O Fatigue/Sleeping/Shoulder/Taste
UK-L Dry mouth Fear Chewing/Fatigue/Swallowing Dental Pain HN Mouth O/ Mucus /Sore mouth
KEY:  Chewing (Chewing/Eating),  Fear (Fear of the cancer coming back), Fatigue (Fatigue/Tiredness), Dental (Dental health/Teeth), Speech (Speech/Voice/Being understood), Pain HN (Pain in 
the head and neck), Cancer T (Cancer treatment), Mouth O (Mouth opening), Wound H (Wound healing), Regret (Regret about treatment), Dependents (Dependents/Children), Support 
(Support for my family), spiritual (Spiritual/Religious aspects)
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Table 5. Case-mix and number of patients reporting a less than good overall QOL 
Patients with less than good overall QOL
Raw data Risk ratio* unadjusted
Risk ratio* after 
adjustment
Gender Male 23% (338/1468) Reference
Female 29% (185/630) 1.28 (1.09-1.49) 1.27 (1.05-1.53)
<55 25% (124/500) ReferenceAge at 
diagnosis 55-64 25% I171/671) 1.03 (0.84-1.26) 1.01 (0.81-1.27)
65-74 22% (148/662) 0.90 (0.73-1.11) 0.92 (0.68-1.23)
≥75 31% (81/262) 1.25 (0.98-1.58) 1.26 (0.89-1.78)
Stage Early 22% (203/938) Reference
Late 28% (318/1144) 1.28 (1.10-1.50) 1.26 (0.94-1.68)
Site Oral 27% (267/1003) Reference
Oropharynx 26% (111/420) 0.99 (0.82-1.20) 0.91 (0.69-1.20)
Larynx 21% (85/414) 0.77 (0.62-0.96) 0.79 (0.57-1.09)
Other 23% (60/257) 0.88 (0.69-1.12) 0.85 (0.65-1.13)
Treatment Surgery only 22% (164/743) Reference
RT+/-CT only 26% (124/480) 1.17 (0.96-1.43) 1.17 (0.83-1.65)
Surgery & RT+/-CT 27% (233/864) 1.22 (1.03-1.45) 1.11 (0.77-1.61)
<12 months 27% (150/551) ReferenceTime from 
diagnosis 12-23 months 29% (118/406) 1.07 (0.87-1.31) 1.09 (0.88-1.34)
24-59 months 21% (129/612) 0.77 (0.63-0.95) 0.78 (0.60-1.02)
≥60 months 24% (114/472) 0.89 (0.72-1.09) 0.93 (0.71-1.21)
*risk ratio  (with 95% confidence interval) for unadjusted and then adjusted for other case-mix factors and for within-unit 
clustering (n=2021 with QOL and all case-mix known)
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Figure 1. Box-plot showing Unit variation in total number of PCI items selected
The PCI contains 56 items
An asterisk represents a value more than 3 box lengths from the upper or lower edge of the 
box, while a circle marks a value between 1.5 and 3 box lengths away from the box.
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Figure 2. Unit variation in the mean number of PCI items selected, total and by PCI domain 
The PCI contains 56 items
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Figure 3 Funnel plot showing the percentage of patients selecting 6 or more PCI items plotted 
against sample size, firstly unadjusted and secondly adjusted for case-mix*
Overall Unadjusted:  2136 patients, 19 units Overall Adjusted: 2053 patients with all case-mix data*, n=18 units
* Adjusted for age (<55, 55-64, 65-74, ≥75), Gender (male, female),  Clinical Stage (Early T1N0, T2N0) or Late), Site (oral, oropharynx, 
larynx, other), Treatment (surgery alone,  radiotherapy  and/or chemotherapy in the absence of surgery, surgery combined with 
radiotherapy and/or chemotherapy) and Months from Primary diagnosis (<12, 12-23, 24-59, ≥60).
Figure 4 Funnel plot showing the adjusted* percentage of patients in each of the 18 units that 
selected more than the median number of PCI items in each domain, plotted against sample size
Physical & functional well-being Treatment  related
Social care & social well-being Psychological, emotional & spiritual well-being
* Adjusted for case-mix (known for 2053): Age (<55, 55-64, 65-74, ≥75), Gender (male, female),  Clinical Stage (Early T1N0, T2N0) or Late), 
Site (oral, oropharynx, larynx, other), Treatment (surgery alone,  radiotherapy  and/or chemotherapy in the absence of surgery, surgery 
combined with radiotherapy and/or chemotherapy) and Months from Primary diagnosis (<12, 12-23, 24-59, ≥60).
Page 31 of 34
John Wiley & Sons, Inc.
Head & Neck
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Figure 5. PCI items selected overall in the study sample of 2136 patients
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Figure 6 Funnel plot showing the percentage of patients reporting less than good overall 
QOL, firstly unadjusted and secondly adjusted for case-mix*
Overall Unadjusted:  2099 patients, 19 units Overall Adjusted: 2021 patients with all case-mix data*, n=18 units
*Adjusted for case-mix (known for 2213): Age (<55, 55-64, 65-74, ≥75), Gender (male, female),  Clinical Stage (Early T1N0, T2N0) or Late), 
Site (oral, oropharynx, larynx, other), Treatment (surgery alone,  radiotherapy  and/or chemotherapy in the absence of surgery, surgery 
combined with radiotherapy and/or chemotherapy) and Months from Primary diagnosis (<12, 12-23, 24-59, ≥60).
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Figure 7 Association between the total number of PCI items selected and the percentage of 
patients reporting less than good overall QOL  (n=2099, 19 units)
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Figure 8 Association between the total number of PCI items selected within each PCI domain 
and the percentage of patients reporting less than good overall QOL  (n=2099, 19 units)
Physical & functional well-being Treatment  related
Social care & social well-being Psychological, emotional & spiritual well-being
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